目的探討缺氧誘導(dǎo)因子-1α(hypoxia induced factor-1α,HIF-1α)基因轉(zhuǎn)染是否提高缺氧間充質(zhì)干細(xì)胞(mesenchymal stem cells,MSCs)的耐缺氧能力以及這種能力是否與增加葡萄糖攝取有關(guān)。方法將MSCs分為常氧非轉(zhuǎn)染組(即對照組)、常氧轉(zhuǎn)染組、缺氧非轉(zhuǎn)染組和缺氧轉(zhuǎn)染組,分別于常氧(5% CO2,37 ℃)和缺氧(94% N2、1% O2和5% CO2,37 ℃)條件下孵育8 h。免疫細(xì)胞化學(xué)、RT-PCR和Western blot法檢測HIF-1α表達(dá),流式細(xì)胞儀檢測細(xì)胞凋亡率(AR)、死亡率(DR),MTT法檢測細(xì)胞增殖,放射同位素法檢測氚標(biāo)葡萄糖(3H-G)攝取量。結(jié)果①與常氧非轉(zhuǎn)染組相比,常氧轉(zhuǎn)染組HIF-1α mRNA表達(dá)明顯增高(P lt;0.01),但其蛋白表達(dá)2組間差異無統(tǒng)計(jì)學(xué)意義(P=0.187); 與缺氧非轉(zhuǎn)染組相比,缺氧轉(zhuǎn)染組的HIF1α mRNA和蛋白表達(dá)均明顯增高(P lt;0.01)。②缺氧轉(zhuǎn)染組MSCs的AR(P=0.001)和DR(P=0.003)均明顯低于缺氧非轉(zhuǎn)染組,但均明顯高于常氧非轉(zhuǎn)染組(P lt;0.01)。③與缺氧非轉(zhuǎn)染組相比,缺氧轉(zhuǎn)染組MSCs增殖(P=0.004)明顯提高,但明顯低于常氧非轉(zhuǎn)染組(P=0.001)。④與缺氧非轉(zhuǎn)染組相比,缺氧轉(zhuǎn)染組MSCs對 3H-G的攝取量明顯提高(P=0.004),但明顯低于常氧非轉(zhuǎn)染組(P=0.001)。⑤AR與HIF-1α蛋白表達(dá)(r=-0.71,P=0.005)、3H-G攝取量(r=-0.65,P=0.004)均呈明顯負(fù)相關(guān),HIF-1α蛋白表達(dá)與3H-G攝取量呈明顯正相關(guān)(r=0.77,P=0.003)。結(jié)論HIF-1α基因可顯著提高M(jìn)SCs的耐缺氧能力,其機(jī)理可能與HIF-1α基因提高M(jìn)SCs對葡萄糖的攝取有關(guān)。
引用本文: 孔宏亮,孫紅波,宋麗杰,齊國先. 缺氧誘導(dǎo)因子-1α過表達(dá)對骨髓間充質(zhì)干細(xì)胞缺氧時(shí)生存能力的影響. 中國普外基礎(chǔ)與臨床雜志, 2011, 18(3): 261-266. doi: 復(fù)制
版權(quán)信息: ?四川大學(xué)華西醫(yī)院華西期刊社《中國普外基礎(chǔ)與臨床雜志》版權(quán)所有,未經(jīng)授權(quán)不得轉(zhuǎn)載、改編
1. | Aceves JL, Archundia A, Díaz G, et al. Stem cell perspectives in myocardial infarctions [J]. Rev Invest Clin, 2005, 57(2): 156162. |
2. | Wollert KC, Drexler H. Clinical applications of stem cells for the heart [J]. Circ Res, 2005, 96: 151163. |
3. | Zimmet JM, Hare JM. Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy [J]. Basic Res Cardiol, 2005, 100(6): 471481. |
4. | Minguell JJ, Erices A. Mesenchymal stem cells and the treatment of cardiac disease [J]. Exp Biol Med (Maywood), 2006, 231(1): 3949. |
5. | 宋來鳳. 從干細(xì)胞誘導(dǎo)成心肌細(xì)胞研究中的理論和技術(shù)瓶頸 [J]. 中華心血管病雜志, 2005, 33(2): 107108. |
6. | Kong HL, Liu NN, Huo Xin, et al. Cell multiplication, apoptosis and pAkt protein expression of bone mesenchymal stem cells of rat under hypoxia environment [J]. JNMU, 2007, 21(4): 233239. |
7. | 孔宏亮, 劉寧寧, 張海鵬, 等. 缺氧環(huán)境下大鼠骨髓間充質(zhì)干細(xì)胞的凋亡及Fas、FasL的表達(dá) [J]. 中國組織化學(xué)與細(xì)胞化學(xué)雜志, 2007, 16(5): 538543. |
8. | 孔宏亮, 劉寧寧, 齊國先, 等. 缺氧對大鼠骨髓間充質(zhì)干細(xì)胞增殖、凋亡及葡萄糖攝取和Akt表達(dá)的影響 [J]. 中國現(xiàn)代醫(yī)學(xué)雜志, 2007, 18(10): 13741382. |
9. | 齊國先, 孔宏亮, 劉寧寧, 等. 缺氧環(huán)境下大鼠骨髓間充質(zhì)干細(xì)胞凋亡相關(guān)蛋白和mRNA的表達(dá) [J]. 中國組織化學(xué)與細(xì)胞化學(xué)雜志, 2008, 17(2): 138143. |
10. | 孔宏亮, 劉寧寧, 霍鑫, 等. Akt基因轉(zhuǎn)染對骨髓間充質(zhì)干細(xì)胞缺氧時(shí)凋亡和增殖的影響 [J]. 中國組織化學(xué)與細(xì)胞化學(xué)雜志, 2008, 17(3): 225231. |
11. | 霍鑫, 孔宏亮, 胡新華, 等. pEGFPC1/Akt體外轉(zhuǎn)染骨髓間充質(zhì)干細(xì)胞后對VEGF表達(dá)的影響 [J]. 中華實(shí)驗(yàn)外科雜志, 2007, 12(3): 206211. |
12. | Kong HL, Li ZQ, Zhao YJ, et al. Cardiac autonomic nerve fiber regeneration in chronic heart failure. Do Akt genetransduced mesenchymal stem cells promote repair? [J]. Neural Regen Res, 2010, 5(1): 2834. |
13. | Salceda S, Caro J. Hypoxiainducible factor 1α (HIF1α) protein is rapidly degraded by the ubiquitinproteasome system under normoxic conditions. Its stabilization by hypoxia depends on redoxinduced changes [J]. J Biol Chem, 1997, 272(36): 2264222647. |
14. | Soucek T, Cumming R, Dargusch R, et al. The regulation of glucose metabolism by HIF1 mediates a neuroprotective response to amyloid beta peptide [J]. Neuron, 2003, 39(1): 4356. |
15. | 胡鳶, 楊柳, 段小軍. 缺氧誘導(dǎo)因子1α基因轉(zhuǎn)染人間充質(zhì)干細(xì)胞 [J]. 第三軍醫(yī)大學(xué)學(xué)報(bào), 2005, 27(9): 928929. |
16. | 胡鳶, 段小軍, 楊柳. 缺氧誘導(dǎo)因子1α基因轉(zhuǎn)染人間充質(zhì)干細(xì)胞的體內(nèi)促血管生成作用 [J]. 中華實(shí)驗(yàn)外科雜志, 2006, 23(8): 993996. |
17. | Zheng X, Ruas JL, Cao R, et al. Celltypespecific regulation of degradation of hypoxiainducible factor 1α: role of subcellular compartmentalization [J]. Mol Cell Biol, 2006, 26(12): 46284641. |
18. | 邵磊, 周書春, 徐桂萍, 等. 體外Akt基因轉(zhuǎn)染對骨髓間充質(zhì)干細(xì)胞葡萄糖轉(zhuǎn)運(yùn)載體4表達(dá)和易位的影響 [J]. 中國普外基礎(chǔ)與臨床雜志, 2010, 17(1): 5256. |
19. | Schipani E. Posttranslational modifications of collagens as targets of hypoxia and Hif1α in endochondral bone development [J]. Ann N Y Acad Sci, 2010, 1192: 317321. |
20. | Westra J, Molema G, Kallenberg CG. Hypoxiainducible factor1 as regulator of angiogenesis in rheumatoid arthritis-therapeutic implications [J]. Curr Med Chem, 2010, 17(3): 254263. |
21. | Rey S, Semenza GL. Hypoxiainducible factor1dependent mechanisms of vascularization and vascular remodelling [J]. Cardiovasc Res, 2010, 86(2): 236242. |
22. | Heddleston JM, Li Z, Lathia JD, et al. Hypoxia inducible factors in cancer stem cells [J]. Br J Cancer, 2010, 102(5): 789795. |
23. | Lin J, Denmeade S, Carducci MA. HIF1α and calcium signaling as targets for treatment of prostate cancer by cardiac glycosides [J]. Curr Cancer Drug Targets, 2009, 9(7): 881887. |
- 1. Aceves JL, Archundia A, Díaz G, et al. Stem cell perspectives in myocardial infarctions [J]. Rev Invest Clin, 2005, 57(2): 156162.
- 2. Wollert KC, Drexler H. Clinical applications of stem cells for the heart [J]. Circ Res, 2005, 96: 151163.
- 3. Zimmet JM, Hare JM. Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy [J]. Basic Res Cardiol, 2005, 100(6): 471481.
- 4. Minguell JJ, Erices A. Mesenchymal stem cells and the treatment of cardiac disease [J]. Exp Biol Med (Maywood), 2006, 231(1): 3949.
- 5. 宋來鳳. 從干細(xì)胞誘導(dǎo)成心肌細(xì)胞研究中的理論和技術(shù)瓶頸 [J]. 中華心血管病雜志, 2005, 33(2): 107108.
- 6. Kong HL, Liu NN, Huo Xin, et al. Cell multiplication, apoptosis and pAkt protein expression of bone mesenchymal stem cells of rat under hypoxia environment [J]. JNMU, 2007, 21(4): 233239.
- 7. 孔宏亮, 劉寧寧, 張海鵬, 等. 缺氧環(huán)境下大鼠骨髓間充質(zhì)干細(xì)胞的凋亡及Fas、FasL的表達(dá) [J]. 中國組織化學(xué)與細(xì)胞化學(xué)雜志, 2007, 16(5): 538543.
- 8. 孔宏亮, 劉寧寧, 齊國先, 等. 缺氧對大鼠骨髓間充質(zhì)干細(xì)胞增殖、凋亡及葡萄糖攝取和Akt表達(dá)的影響 [J]. 中國現(xiàn)代醫(yī)學(xué)雜志, 2007, 18(10): 13741382.
- 9. 齊國先, 孔宏亮, 劉寧寧, 等. 缺氧環(huán)境下大鼠骨髓間充質(zhì)干細(xì)胞凋亡相關(guān)蛋白和mRNA的表達(dá) [J]. 中國組織化學(xué)與細(xì)胞化學(xué)雜志, 2008, 17(2): 138143.
- 10. 孔宏亮, 劉寧寧, 霍鑫, 等. Akt基因轉(zhuǎn)染對骨髓間充質(zhì)干細(xì)胞缺氧時(shí)凋亡和增殖的影響 [J]. 中國組織化學(xué)與細(xì)胞化學(xué)雜志, 2008, 17(3): 225231.
- 11. 霍鑫, 孔宏亮, 胡新華, 等. pEGFPC1/Akt體外轉(zhuǎn)染骨髓間充質(zhì)干細(xì)胞后對VEGF表達(dá)的影響 [J]. 中華實(shí)驗(yàn)外科雜志, 2007, 12(3): 206211.
- 12. Kong HL, Li ZQ, Zhao YJ, et al. Cardiac autonomic nerve fiber regeneration in chronic heart failure. Do Akt genetransduced mesenchymal stem cells promote repair? [J]. Neural Regen Res, 2010, 5(1): 2834.
- 13. Salceda S, Caro J. Hypoxiainducible factor 1α (HIF1α) protein is rapidly degraded by the ubiquitinproteasome system under normoxic conditions. Its stabilization by hypoxia depends on redoxinduced changes [J]. J Biol Chem, 1997, 272(36): 2264222647.
- 14. Soucek T, Cumming R, Dargusch R, et al. The regulation of glucose metabolism by HIF1 mediates a neuroprotective response to amyloid beta peptide [J]. Neuron, 2003, 39(1): 4356.
- 15. 胡鳶, 楊柳, 段小軍. 缺氧誘導(dǎo)因子1α基因轉(zhuǎn)染人間充質(zhì)干細(xì)胞 [J]. 第三軍醫(yī)大學(xué)學(xué)報(bào), 2005, 27(9): 928929.
- 16. 胡鳶, 段小軍, 楊柳. 缺氧誘導(dǎo)因子1α基因轉(zhuǎn)染人間充質(zhì)干細(xì)胞的體內(nèi)促血管生成作用 [J]. 中華實(shí)驗(yàn)外科雜志, 2006, 23(8): 993996.
- 17. Zheng X, Ruas JL, Cao R, et al. Celltypespecific regulation of degradation of hypoxiainducible factor 1α: role of subcellular compartmentalization [J]. Mol Cell Biol, 2006, 26(12): 46284641.
- 18. 邵磊, 周書春, 徐桂萍, 等. 體外Akt基因轉(zhuǎn)染對骨髓間充質(zhì)干細(xì)胞葡萄糖轉(zhuǎn)運(yùn)載體4表達(dá)和易位的影響 [J]. 中國普外基礎(chǔ)與臨床雜志, 2010, 17(1): 5256.
- 19. Schipani E. Posttranslational modifications of collagens as targets of hypoxia and Hif1α in endochondral bone development [J]. Ann N Y Acad Sci, 2010, 1192: 317321.
- 20. Westra J, Molema G, Kallenberg CG. Hypoxiainducible factor1 as regulator of angiogenesis in rheumatoid arthritis-therapeutic implications [J]. Curr Med Chem, 2010, 17(3): 254263.
- 21. Rey S, Semenza GL. Hypoxiainducible factor1dependent mechanisms of vascularization and vascular remodelling [J]. Cardiovasc Res, 2010, 86(2): 236242.
- 22. Heddleston JM, Li Z, Lathia JD, et al. Hypoxia inducible factors in cancer stem cells [J]. Br J Cancer, 2010, 102(5): 789795.
- 23. Lin J, Denmeade S, Carducci MA. HIF1α and calcium signaling as targets for treatment of prostate cancer by cardiac glycosides [J]. Curr Cancer Drug Targets, 2009, 9(7): 881887.